NASDAQ NMS - GLOBAL MARKET · PCRX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Pacira Biosciences Inc

Pacira Biosciences Inc

Pharmaceuticals
$25.39

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is PCRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Pacira Biosciences Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2011
Employees
829
Country
US

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$25.39
Last session
Day high
$25.39
Last session
Day low
$25.39
Last session
Previous close
$25.39
52W high
$25.39
0.00% from high
52W low
$25.39
Market cap
$999M
P/E
194.38×
EPS
$-3.0000
Shares out
39.3M
VWAP
$25.39
Last session
Veridion warehouse edge

Warehouse intelligence for PCRX.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

PCRX insider activity

Pacira Biosciences Inc

Score
Coverage building
Pressure
Net selling
Filings
37
Buys / sells
7 / 30
Net value
-$4.1M
Insiders
9
Named filers
RL
RIKER LAUREN
Insider
Leadership
WK
WILLIAMS KRISTEN
Insider
Leadership
SJ
SLONIN JONATHAN
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$4.1M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-122026-06-11RIKER LAURENInsidersell$23.506,11562,284$144KSEC Form 4
2026-06-052026-06-04WILLIAMS KRISTENInsidersell$22.2710,259167,062$228KSEC Form 4
2026-06-052026-06-03RIKER LAURENInsidersell$22.323,18768,399$71KSEC Form 4
2026-06-052026-06-03SLONIN JONATHANInsidersell$22.324,728218,912$106KSEC Form 4
2026-06-052026-06-03WILLIAMS KRISTENInsidersell$22.328,528177,321$190KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 32 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

PCRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PCRX in this window.
Lobbying spend

PCRX lobbying filings, year to date.

Registered lobbying filings matched to Pacira Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PCRX in this window.
Latest news · PCRX
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for PCRX.
Options
Sovereign unlock shows live options positioning for PCRX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.